WHOLE BLOOD for SERUM/DNA BANKING SUBMISSION REPORT Quality Of Life Companion Study For JMA27 (NCIC-MA.27): A Randomized Phase III Trial Of Exemestane Versus Anastrozole With Or Without Celecoxib In Postmenopausal Women With Receptor Positive Primary Breast Cancer Source Form: NCI FormBuilder:



  1. 8/26/12 8/26/12 -
  2. 1/9/15 1/9/15 - Martin Dugas
Uploaded on

January 9, 2015


To request one please log in.


Creative Commons BY-NC 3.0 Legacy

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Breast Cancer NCT00090974 Transmittal - WHOLE BLOOD for SERUM/DNA BANKING SUBMISSION REPORT - 2058882v3.0

To be submitted with Form 1 - Eligibility Checklist and Initial Evalution within 6 weeks of randomization.

Patient Information
Whole Blood Submission
Unnamed question (specimen type) (check one)
Investigator Signature
Ccrr Module For Whole Blood For Serum/dna Banking Submission Report

Similar models

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial